secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001522767-23-000119
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q3 revenue $38.8M (+14% YoY), GAAP net loss of $4.3M vs profit a year ago
--------------------------------------------------------------------------------

- Revenue of $38.8M for Q3 2023, up 14% from $33.9M in Q3 2022.
- GAAP net loss of $4.3M, compared to net income of $2.7M in the prior-year quarter.
- Non-GAAP adjusted EBITDA of $6.1M (16% margin) vs $8.6M (25% margin) a year ago.
- Reported 15th consecutive quarter of positive adjusted EBITDA.
- Maryland adult-use sales launched July 1; wholesale business set quarterly records.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/mrmd-20231108.htm
  HTML page:      https://secwatch.observer/filing/0001522767-23-000119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer